83 results
8-K
OCUL
Ocular Therapeutix Inc
18 Apr 24
Departure of Directors or Certain Officers
4:12pm
served as President of IVERIC bio, Inc., a biopharmaceutical company, from May 2021 to October 2023, and as Executive Vice President, Chief Strategy
S-3ASR
OCUL
Ocular Therapeutix Inc
25 Mar 24
Automatic shelf registration
4:40pm
by reference herein, including statements regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects … of the Association of Southeast Asian Nations;
our capabilities and strategy, and the costs and timing of manufacturing, sales, marketing, distribution
8-K
EX-99.1
6fojc
11 Mar 24
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results
4:10pm
8-K
9df rmht8u27unfh5kn7
22 Feb 24
Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
7:34am
424B5
ra0r6gsg 34d49aml
14 Dec 23
Prospectus supplement for primary offering
4:09pm
424B5
zq1jfldu
13 Dec 23
Prospectus supplement for primary offering
4:10pm
8-K
EX-99.1
tesqoh630n6zmbaa
7 Aug 23
Ocular Therapeutix™ Provides Second Quarter 2023 Financial Results and Corporate Update
4:06pm
8-K
EX-99.1
h6gsxcf7
8 May 23
Ocular Therapeutix™ Provides First Quarter 2023 Financial Results and Corporate Update
4:04pm